SCHEMBL4840179

SCHEMBL4840179

CC(C)(C)c1cc(Oc2ccc([N+](=O)[O-])c(O)c2)ccc1Oc1ccc([N+](=O)[O-])c(O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
NPSR1 Q6W5P4 2/20 0.44
HPGD P15428 1/20 0.44
ESRRA P11474 4/20 0.44
NR1H4 Q96RI1 3/20 0.43
GAA P10253 1/20 0.43
GPR35 Q9HC97 1/20 0.43
TDP1 Q9NUW8 3/20 0.41
HTT P42858 3/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
TTR P02766 1/20 0.40
PPOX P50336 1/20 0.40
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GALR3 O60755 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MAPT P10636 2/20 0.38
HSPB1 P04792 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4847049 0.81 GPR35 (0.58) ALDH1A1HPGDGPR35TDP1HTT
SCHEMBL30176239 0.80 HTT (0.54) ALDH1A1NPSR1NR1H4GAAHTT
SCHEMBL27717441 0.78 ALDH1A1 (0.60) ALDH1A1NPSR1HPGDNR1H4GAA
SCHEMBL4843320 0.78 GPR35 (0.51) ALDH1A1NPSR1HPGDGAAGPR35
SCHEMBL4839671 0.78 GPR35 (0.55) ALDH1A1HPGDGAAGPR35TDP1
SCHEMBL5955410 0.77 LTA4H (0.52) ALDH1A1NPSR1HPGDGAAGPR35
SCHEMBL4840927 0.76 GPR35 (0.53) ALDH1A1HPGDGPR35TDP1HTT
SCHEMBL4841646 0.76 ALDH1A1 (0.48) ALDH1A1HPGDESRRANR1H4GAA
SCHEMBL4845296 0.76 GPR35 (0.49) ALDH1A1HPGDGAAGPR35TDP1
SCHEMBL10946853 0.75 MEN1 (0.56) ALDH1A1NPSR1HPGDTDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365231-B2 Compound with antitumor activity and preparation method therefor NATIONAL TAIWAN UNIVERSITY OF SCIENCE & TECHNOLOGY (TW) 2008-04-29 US disclosed
US-20060241187-A1 Compound with antitumor activity and preparation method therefor NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (TW) 2006-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241187-A1 Compound with antitumor activity and preparation method therefor WEE1, WEE2, CYP51A1 ALDH1A1 206/4885NPSR1 1696/4885HPGD 236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.